CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets [Phase 1]
Summary
Phase 1 study reporting the relative bioavailability of hydroxychloroquine sulfate 200 mg tablets; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sandoz | Conditions: Immunosuppression, Rheumatism | Phase 1 | Status: COMPLETED